Series Overview

The Collaborative Genomics Conference is a bi-monthly web-based clinical case conference series that brings together clinical laboratorians and clinicians from across the country to share interesting and unusual patient cases in the field of medical genetics, as well as educate one another about current and advanced genetic and genomic diagnostic technologies and guidelines. This series aims to keep learners updated on overall genetic knowledge, to enhance communication and genetic information across clinical specialties, and to ultimately improve clinical laboratory practices for enhanced patient care. 

Global Objectives

As a result of participation in this educational series, members of the healthcare team will:

• Interpret both common and rare genetic abnormalities associated with prenatal, postnatal and somatic/cancer specimens.
• Demonstrate an improved ability to effectively communicate genetic information across healthcare professions and clinical team members.
• Examine performance and utility of multiple genetic and genomic testing approaches and standardized classification recommendations.

Intended Audience

MD/DO, APRN, Genetic Counselors, Non-Clinician Researchers, Clinical Laboratorians, LGG Fellows, and Students.

Planning Committee

Accreditation

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.

* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies.

Detailed disclosures will be available prior to the start of the activity.

Disclosures for Planning Committee

COMPETENCIES

ACGME/NURSING

• Medical Knowledge
• Practice-Based Learning and Improvement
• Interpersonal and Communication Skills

INTERPROFESSIONAL EDUCATION COLLABORATIVE 

• Interprofessional Communication

ADDITIONAL ACTIVITY GOALS

IP — COMPETENCE/PERFORMANCE